在固体瘤中提供CAR-T细胞和疗效的生理学基础的药物动力学模型
bioRxiv : the preprint server for biology
|September 2, 2025
概括
通过使用抗VEGF疗法进行血管正常化,通过使瘤微环境更有支持性来改善固体瘤的CAR- T细胞治疗. 这种方法增强了T细胞的透,并显著降低了所需的CAR- T细胞剂量.
科学领域:
- 免疫学
- 癌症学
- 计算生物学
背景情况:
- 异常的瘤血管阻碍了T细胞在瘤微环境中的有效性.
- 在临床前的质母细胞瘤模型中,使用抗VEGF治疗的血管正常化已显示出改善CAR- T细胞治疗结果的前景.
研究的目的:
- 在固体瘤血管正常化后模拟CAR- T细胞和内源性免疫细胞动态的药理学模型的开发.
- 优化CAR-T治疗策略,包括固体瘤的剂量,时间表和输送途径.
主要方法:
- 基于生理学的药物动力学模型的开发.
- 在固体瘤中模拟CAR-T细胞和内生免疫细胞动态.
- 对TME组成和CAR-T细胞疗效的血管正常化影响的分析.
主要成果:
- 血管正常化将TME重新编程为免疫支持,增强CD8+T细胞和CAR-T细胞的透.
- M1巨细胞增加,而M2巨细胞和调节性T细胞减少,从而提高疗效.
- 预计CAR- T细胞剂量将减少十倍,最佳时间安排可增强抗瘤功能.
结论:
- 血管正常化是加强固体瘤CAR- T细胞治疗的关键策略.
- 开发的模型为优化CAR-T治疗参数提供了一个框架.
- 结合血管和脑膜正常化可能有利于脱质瘤,局部分娩可以改善结果.
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
79
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
79
Pharmacokinetic Models: Comparison and Selection Criterion
147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Model Approaches for Pharmacokinetic Data: Physiological Models
108
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
108
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
126
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
126
Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
Physiological Pharmacokinetic Models: Assumption with Protein Binding
91
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
91


